Cognex Acquires RealSense for $600 Million and Expands Into Robot Vision
Investors sold CGNX on valuation and cash spend.
Already have an account? Sign in.
Investors sold CGNX on valuation and cash spend.
FDA clears TriSalus’ TriNav Advance, designed to push more treatment into liver tumors and less into healthy tissue via a SmartValve.
The company says real-time quantum error decoding can run in the background on commodity hardware instead of custom FPGA, GPU, or ASIC farms.
Vanguard’s reported $4B–$4.6B Altruist deal revived fears that AI will disrupt brokerage custody and idle client cash that funds broker profits.